$323 Million is the total value of Antipodean Advisors LLC's 10 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 40.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CVNA | CARVANA COcl a | $106,272,000 | +9.5% | 405,000 | 0.0% | 32.85% | +20.6% | |
| SE | SEA LTDsponsord ads | $78,131,000 | +12.1% | 350,000 | 0.0% | 24.15% | +23.4% | |
| CDLX | Sell | CARDLYTICS INC | $70,076,000 | -25.2% | 638,800 | -2.6% | 21.66% | -17.6% |
| CLVT | CLARIVATE PLC | $33,647,000 | -11.2% | 1,275,000 | 0.0% | 10.40% | -2.2% | |
| ATRA | ATARA BIOTHERAPEUTICS INC | $14,360,000 | -26.8% | 1,000,000 | 0.0% | 4.44% | -19.5% | |
| HLF | Sell | HERBALIFE NUTRITION LTD | $12,181,000 | -32.4% | 274,600 | -26.8% | 3.77% | -25.6% |
| GOTU | New | GSX TECHEDU INCsponsored ads | $3,974,000 | – | 117,284 | +100.0% | 1.23% | – |
| FVRR | Sell | FIVERR INTL LTD | $2,172,000 | -62.9% | 10,000 | -66.7% | 0.67% | -59.2% |
| MPLN | New | MULTIPLAN CORPORATION | $1,909,000 | – | 344,000 | +100.0% | 0.59% | – |
| NKLA | Sell | NIKOLA CORP | $750,000 | -68.1% | 53,999 | -64.9% | 0.23% | -64.8% |
| NOVSW | Exit | NOVUS CAP CORP*w exp 06/30/202 | $0 | – | -11,905 | -100.0% | -0.02% | – |
| AMZN | Exit | AMAZON COM INC | $0 | – | -3,662 | -100.0% | -3.35% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CARVANA CO | 21 | Q2 2023 | 38.5% |
| AMAZON COM INC | 20 | Q4 2020 | 33.8% |
| SEA LTD | 19 | Q3 2023 | 60.8% |
| CARDLYTICS INC | 18 | Q3 2023 | 26.3% |
| MEDICINES CO | 18 | Q4 2019 | 19.8% |
| ATARA BIOTHERAPEUTICS INC | 15 | Q3 2023 | 17.9% |
| CONSTELLATION BRANDS INC | 14 | Q4 2016 | 11.1% |
| HERBALIFE NUTRITION LTD | 13 | Q1 2021 | 24.8% |
| CLARIVATE PLC | 11 | Q4 2021 | 24.4% |
| EXACT SCIENCES CORP | 11 | Q2 2019 | 24.6% |
View Antipodean Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Oncothyreon Inc.Sold out | January 09, 2013 | 0 | 0.0% |
View Antipodean Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
| 13F-HR | 2021-08-16 |
View Antipodean Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.